The Increased Burden of Community-Onset Clostridium difficile Infection Aaron Smith , B.S. 1 , Brandon Wuerth, B.S. 1 , Forest Arnold, D.O., M.Sc. 1 Department of Medicine, Division of Infectious Diseases 1 University of Louisville School of Medicine. Conclusions. Introduction. Methods.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
The Increased Burden of Community-Onset Clostridium difficile Infection Aaron Smith, B.S.1, Brandon Wuerth, B.S.1, Forest Arnold, D.O., M.Sc.1Department of Medicine, Division of Infectious Diseases1University of Louisville School of Medicine
Clostridium difficile infection (CDI) has traditionally been recognized as a common cause of diarrhea acquired in the healthcare setting. The more severe manifestation of CDI is pseudomembranous colitis, which can lead to toxic megacolon, colonic perforation, or even death. In fact, more deaths have been attributed to CDI than all other intestinal infections combined.1 Three broad categories of CDI exist, nosocomial (acquired in the hospital), community-acquired, and community-onset (unknown site of origin).One study found that 41% of CDI cases were community-onset of which half were actually community-associated.2
The incidence of CDI has been on the rise since the mid to late 1990’s.3 There was an increase in incidence in 1996 from 31/100,000 population to 61/100,000 population in 2003.3 In addition, a concomitant increase in the mortality rate due to CDI has been shown in recent years.1 A study showed a rise in 1999 from 5.7 deaths/1,000,000 population to 23.7 deaths/1,000,000 population in 2004.1 Regarding length of stay (LOS) and hospital charges, the median duration was 10 days with median charges of $32,597.4
Risk factors for hospital-acquired CDI include inpatient hospitalization, increased hospital LOS and antibiotic use.5 In 2008, the European Centre for Disease Control and Prevention recommended physicians avoid high-risk agents such as cephalosporins, fluoroquinolones and clindamycin in at-risk patients.6
Particularly in recent years, community-acquired CDI has been shown to lack these classic risk factors.2,7-9 The US Centers for Disease Control and Prevention (CDC) reported in December 2005 two cases of severe CDI in populations previously thought to be at low risk – pregnant women and healthy children.10 A case-control study found that only 45% of community-associated CDI patients had been hospitalized in the preceding six months with only 52% having antimicrobials in the previous four weeks.8 Further, the study found that contact with infants less than or equal to two years of age had an increased risk association with CDI.8 Among community-associated CDI cases, patients who required hospitalization were significantly older (64 versus 44 years), were more likely to have severe disease and had higher mean Charlson comorbidity index scores than those who did not require hospitalization.11
Many studies have focused their attention on nosocomial CDI. With the spread of CDI outside the hospital environment, it is also important to track the changes of such a deadly pathogen in the community. The objective of this study was to provide an updated population based analysis of the incidence, mortality rate, hospital charges, and LOS regarding patients with community-onset CDI.
This was a secondary analysis of the Nationwide Emergency Department Sample (NEDS) database, developed as part of the Healthcare Cost and Utilization Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ). Approximating a 20% stratified sample of U.S. hospital-based EDs, the NEDS database is the largest all-payer emergency department database constructed from both the HCUP State Emergency Department Database and the State Inpatient Databases. The AHRQ developed this database specifically to analyze healthcare economics and outcomes. The dataset contains patient information such as age, region, sex, LOS, emergency department (ED) and hospital charges, discharge diagnosis and discharge status.12
The number of states submitting data varies from year to year. The database has grown, incorporating data from 24 states and 950 hospitals to 29 states and 964 hospitals over the course of the four year study period; 2006-2009. To account for this disparity, the database has assigned, individualized discharge weights that were used to produce population level event estimates for each year.12
We queried the database using International Classification of Disease, 9th revision, clinical modification (ICD-9-CM) code 008.45 (intestinal infection due to Clostridium difficile) for 2006-2009. We obtained patient data with C. difficile listed as the principle diagnosis, indicating the patient was admitted primarily due to CDI. The data was stratified by sex, age group, hospital characteristics, LOS, hospitalization costs, mortality rate, and geographical region. We obtained population estimates from U.S. census data, stratified similarly by year, age group and geographical region.13 Using the total ED visits from the NEDS database and the population estimates from the census data, we tabulated the ED incidence of CDI within the U.S. population. All descriptive statistics were completed using Microsoft Excel (Microsoft Corporation, Redmond, WA, USA 2011). During the analysis, the unit of analysis was each ED visit while the stratification unit was the NEDS hospital stratum. Institutional Review Board exemption was obtained because this study used a de-identified public database.
Our study had some limitations, including using ICD-9 coding as our case identifier which could alter our results due to misclassification. If we had false positive cases due to incorrect ICD-9 coding, then the severity may have actually been lower than we found.